Sitemap > Breaking Research > Diagnostics & Devices
Displaying 901 - 950 of 1058 results
- Sensor-Augmented Insulin Pump Therapy: Results of the First Randomized Treat-to-Target Study.
- The Accuracy and Efficacy of Real-Time Continuous Glucose Monitoring Sensor in Patients with Type 1 Diabetes.
- Overexpression of Tyrosine Kinase B Protein as a Predictor for Distant Metastases and Prognosis in Gastric Carcinoma.
- Proteomics-based identification of autoantibody against CDC25B as a novel serum marker in esophageal squamous cell carcinoma.
- Hepatocellular carcinoma metastatic to skin: diagnostic utility of antihuman hepatocyte antibody in combination with albumin in situ hybridization.
- The effect of high intensity focused ultrasound treatment on metastases in a murine melanoma model.
- IL-7 Enhances Human Antigen-specific Memory T-cell Responses: Importance for Improved Diagnosis of Tuberculosis Infection.
- Noninvasive detection of cardiac repair after acute myocardial infarction in rats by (111)in fab fragment of monoclonal antibody specific for tenascin-C.
- Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.
- CA 19-9 as a Predictor for Response and Survival in Advanced Pancreatic Cancer Patients Treated with Chemoradiotherapy.
- Regulation of p53R2 and its role as potential target for cancer therapy.
- Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.
- Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody construct.
- A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease.
- Radioisotopic Localization of (90)Yttrium-Ibritumomab Tiuxetan in Patients with CD20+ Non-Hodgkin's Lymphoma.
- Catheter Ablation of Atrial Fibrillation in Patients with Diabetes Mellitus Type 2: Results from a Randomized Study Comparing Pulmonary Vein Isolation Versus Antiarrhythmic Drug Therapy.
- Clinical Implications of Elevated Pretreatment Carcinoembryonic Antigen in Patients with Advanced Squamous Cell Carcinoma of the Uterine Cervix.
- Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
- Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.
- CD133 expression is an independent prognostic marker for low survival in colorectal cancer.
- CYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantation.
- In Vivo Positron Emission Tomography (PET) Imaging with an alphavbeta6 Specific Peptide Radiolabeled using (18)F-"Click" Chemistry: Evaluation and Comparison with the Corresponding 4-[(18)F]Fluorobenzoyl- and 2-[(18)F]Fluoropropionyl-Peptides.
- Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study.
- Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions.
- Technetium-99m pyrophosphate/thallium-201 dual-isotope SPECT imaging predicts reperfusion injury in patients with acute myocardial infarction after reperfusion.
- Development of high-throughput screening system for osteogenic drugs using a cell-based sensor.
- Synthesis of [(11)C]FEDAA1106 as a new PET imaging probe of peripheral benzodiazepine receptor expression.
- Synthesis and biodistribution of a novel (99m)TcN complex of ciprofloxacin dithiocarbamate as a potential agent for infection imaging.
- Noninvasive imaging of cell proliferation following mitogenic extracellular kinase inhibition by PD0325901.
- Docking study, synthesis, and in vitro evaluation of fluoro-MADAM derivatives as SERT ligands for PET imaging.
- Cleaved forms of the urokinase plasminogen activator receptor in plasma have diagnostic potential and predict postoperative survival in patients with ovarian cancer.
- Clinical Usefulness of EGFR Gene Copy Number as a Predictive Marker in Colorectal Cancer Patients Treated with Cetuximab: A Fluorescent In situ Hybridization Study.
- A Phase II Clinical Trial of Oral Valproic Acid in Patients with Castration-Resistant Prostate Cancers Using an Intensive Biomarker Sampling Strategy.
- Value of BNP and tumour marker CA125 in patients with heart failure.
- Gemcitabine Combined with Gefitinib in Patients with Inoperable or Metastatic Pancreatic Cancer: A Phase II Study of the Hellenic Cooperative Oncology Group with Biomarker Evaluation.
- The Positron Emission Tomography Ligand DAA1106 Binds With High Affinity to Activated Microglia in Human Neurological Disorders.
- Imaging of deep venous thrombosis in patients using a radiolabelled anti-D-dimer Fab' fragment ((99m)Tc-DI-DD3B6/22-80B3): results of a phase I trial.
- Synthesis, ex vivo evaluation, and radiolabeling of potent 1,5-diphenylpyrrolidin-2-one cannabinoid subtype-1 receptor ligands as candidates for in vivo imaging.
- Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study.
- Percutaneous pulsed radiofrequency reduces mechanical allodynia in a neuropathic pain model.
- Design, Synthesis, and Biological Evaluation of an Antagonist-Bombesin Analogue as Targeting Vector.
- Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.
- Use of the QuantiFERON-TB Gold In-Tube((R)) test to monitor treatment efficacy in active pulmonary tuberculosis.
- Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials.
- MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
- High expression of TROP2 correlates with poor prognosis in pancreatic cancer.
- Usage patterns and 2-year outcomes with the TAXUS express stent: Results of the US ARRIVE 1 registry.
- Examining the acute effects of cediranib (RECENTIN, AZD2171) treatment in tumor models: a dynamic contrast-enhanced MRI study using gadopentate.
- A Novel Multipurpose Monoclonal Antibody for Evaluating Human c-Met Expression in Preclinical and Clinical Settings.
- Preparation and pharmacological evaluation of a new radiopharmaceutical, technetium-99m-5-fluorouracil, for tumor scintigraphy.